SWP
AZN icon

Stratos Wealth Partners’s AstraZeneca AZN Stock Holding History

Stratos Wealth Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.05M Sell
5,326
-329
-6% -$63.4K 0.01% 777
2025
Q4 		$1.04M Buy
5,655
+581
+11% +$102K 0.01% 756
2025
Q3 		$779K Sell
5,074
-17
-0.3% -$2.57K 0.01% 850
2025
Q2 		$712K Sell
5,091
-185
-4% -$25.9K 0.01% 812
2025
Q1 		$776K Sell
5,276
-1,462
-22% -$212K 0.01% 743
2024
Q4 		$883K Sell
6,738
-418
-6% -$58.5K 0.01% 738
2024
Q3 		$1.12M Buy
7,156
+85
+1% +$13.7K 0.02% 641
2024
Q2 		$1.1M Sell
7,071
-227
-3% -$34.2K 0.02% 612
2024
Q1 		$989K Buy
7,298
+501
+7% +$66.3K 0.02% 652
2023
Q4 		$916K Sell
6,797
-130
-2% -$16.9K 0.02% 662
2023
Q3 		$938K Buy
6,927
+432
+7% +$59K 0.02% 600
2023
Q2 		$930K Buy
6,495
+1,697
+35% +$250K 0.02% 558
2023
Q1 		$666K Sell
4,798
-1,919
-29% -$258K 0.02% 594
2022
Q4 		$911K Sell
6,717
-239
-3% -$30K 0.02% 534
2022
Q3 		$763K Sell
6,956
-535
-7% -$67.9K 0.02% 558
2022
Q2 		$990K Sell
7,491
-1,466
-16% -$192K 0.03% 519
2022
Q1 		$1.19M Sell
8,957
-98
-1% -$11.8K 0.03% 509
2021
Q4 		$1.05M Sell
9,055
-3,007
-25% -$354K 0.02% 546
2021
Q3 		$1.45M Sell
12,062
-313
-3% -$36.4K 0.04% 418
2021
Q2 		$1.48M Sell
12,375
-1,752
-12% -$192K 0.04% 427
2021
Q1 		$1.41M Buy
14,127
+514
+4% +$51.7K 0.04% 408
2020
Q4 		$1.36M Buy
13,613
+8,443
+163% +$894K 0.04% 367
2020
Q3 		$567K Sell
5,170
-119
-2% -$13.2K 0.02% 579
2020
Q2 		$560K Buy
+5,289
New +$546K 0.02% 559
2018
Q2 		– Sell
-2,024
Closed -$142K – 1096
2018
Q1 		$142K Buy
2,024
+159
+9% +$11K 0.01% 1029
2017
Q4 		$129K Sell
1,865
-1,819
-49% -$123K 0.01% 1050
2017
Q3 		$250K Buy
+3,684
New +$233K 0.01% 763
2014
Q3 		– Sell
-11,981
Closed -$891K – 333
2014
Q2 		$891K Buy
+11,981
New +$866K 0.3% 98

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Stratos Wealth Partners's AZN Position: Q1 2026 in Review

Stratos Wealth Partners reduced its AstraZeneca (AZN) stake by 5.8% in Q1 2026, selling an estimated $63.4K and leaving 5,326 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #777.

Stratos Wealth Partners first reported a position in AZN in Q2 2014 and has held it in 28 quarters since. The position peaked at $1.48M in Q2 2021. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Stratos Wealth Partners held 5,326 shares of AstraZeneca worth $1.05M as of Q1 2026.
  • Stratos Wealth Partners sold 329 AstraZeneca shares in Q1 2026, an estimated $63.4K.
  • AstraZeneca made up 0.01% of Stratos Wealth Partners's portfolio in Q1 2026, its #777 holding.
  • Stratos Wealth Partners first reported a position in AstraZeneca in Q2 2014 and has held it in 28 quarters since.
  • Stratos Wealth Partners's AstraZeneca position peaked at $1.48M in Q2 2021.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Stratos Wealth Partners's 13F filing for Q1 2026, filed 28 Apr 2026.